Clinical Trials Logo
  1. Home
  2. Premature Infant
  3. NCT03241082
  4. Details
NCT03241082 Clinical Trial

Ultrasound Assessment of BC in the NICU

Premature Infant Clinical Trial

Official title:
Use of Bedside Ultrasound to Assess Neonatal Body Composition in the Neonatal Intensive Care Unit

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03241082
Other study ID # PEDS-2017-25699
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 23, 2017
Est. completion date December 31, 2024

Study information
Verified date March 2024
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The overall objective of the proposal is to evaluate the ability of ultrasound to predict and routinely (weekly) monitor changes in the body composition of healthy preterm infants in the neonatal intensive care unit (NICU) in response to nutritional intake. The investigators hypothesize that ultrasound is an accurate method to routinely monitor the quality of weight gain and assess the adequacy of nutritional provision for premature infants in the neonatal intensive care unit. The investigators will address the hypothesis in the following Specific Aims: Specific Aim 1: Validate ultrasound as a method to measure whole body fat mass and fat free mass in healthy, premature infants. Body composition will be assessed using ultrasound measurements and the validated method of air displacement plethysmography (ADP). Stable isotope dilution techniques will be used in a subset of our population as a secondary source of validation. Specific Aim 2: Determine whether ultrasound measurements can detect clinically relevant (weekly) changes in body composition in healthy premature infants. Ultrasound will be used to obtain serial (weekly) measurements of muscle and adipose tissue thickness (triceps, abdomen, quadriceps) until discharge in healthy, premature infants.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 68
Est. completion date December 31, 2024
Est. primary completion date January 31, 2022
Accepts healthy volunteers No
Gender All
Age group 25 Weeks to 34 Weeks
Eligibility Inclusion Criteria: - Healthy, premature infants 25-34+6 weeks gestational age at birth - Admitted to the University of Minnesota Masonic Children's Hospital NICU - Stable on room air or can be removed from respiratory support for 5 minutes - Written or verbal (telephone) informed consent can be secured from a parent within 1 week of admission to the NICU Exclusion Criteria: -Require medical support preventing ADP measurements

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• ultrasound
validation of portable ultrasound to measure body composition

Locations
Country Name City State
United States University of Minnesota Masonic Children's Hospital Minneapolis Minnesota

Sponsors (1)
Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Whole-body measurements of body composition Measurement of whole body fat mass and fat-free mass via air displacement plethysmography and stable isotope dilution. Up to 6 weeks
See also
  Status Clinical Trial Phase
Terminated NCT02550054 - Erythropoietin in Premature Infants to Prevent Encephalopathy Phase 2
Completed NCT03827252 - Respiratory Stability and Vegetative Coupling During Neonatal Skin-to-skin Care
Active, not recruiting NCT03345069 - Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
Completed NCT04067206 - The Effects Of Auditory Interventions On Pain And Comfort In Premature Infants N/A
Completed NCT03911674 - Effects of Oral Stimulation in Preterm Infants Phase 3
Completed NCT03324126 - Individualized Fortification of Breast Milk N/A
Completed NCT03704012 - Efficacy of Massage Applied by the Parents in Hospitalized Premature Birth (PreMas) N/A
Completed NCT03701906 - Effect of a Mixture of New Probiotic Strains in Preterm Infants N/A
Completed NCT02133716 - Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm Phase 4
Not yet recruiting NCT05543005 - Efficacy Study of an Audio Device Outside Incubator Allowing Broadcasting Maternal Voice on Stability in Preterm Infants N/A
Recruiting NCT03852641 - Feeding Premature Infants During Non-invasive Respiratory Support N/A
Active, not recruiting NCT03423914 - Efficacy of Expressive Writing in Mothers of Preterm Infants N/A
Recruiting NCT04648787 - A Study of Family-integrated Care for Reducing Uncertainty N/A
Recruiting NCT04866342 - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor N/A
Not yet recruiting NCT02601872 - Erythropoietin in Premature Infants to Prevent Encephalopathy Phase 2
Not yet recruiting NCT02534090 - Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy N/A
Recruiting NCT06212427 - Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) N/A
Suspended NCT03939169 - The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP) N/A
Completed NCT03706586 - The Hilo Pilot -Trial to Assess Feasibility N/A
Completed NCT03726697 - Effect of Tahneek on Hypoglycemia in Newborn Infants N/A